A012103: OptimICE-pCR: De-Escalation of Therapy in Early-Stage TNBC Patients who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy

Title
OptimICE-pCR: De-Escalation of Therapy in Early-Stage TNBC Patients who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
Principal Investigator
Safi, Danish
Phase
III
Age Group
Adult
Applicable Disease Sites
Breast Cancer
Participating Institutions
Camden Clark Medical Center
Mary Babb Randolph Cancer Center
United Hospital Center
Contacts
Sabrina Rexroad, RN
Research Nurse
Email:
Melissa Boggess, RN
Research Nurse
Phone: +1 304-487-7515
Email:
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585
Email:
Nnennaya Opara
Clinical Research Specialist
Phone: +1 681-342-1000
Email:
Kaitlyn Hager
Research Nurse
Email:

View on ClinicalTrials.gov